glp-1 supply news november 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Pipeline Update: November 2025

7 CDC / clinical guidanceBest practices for safe subcutaneous injection technique and sharps handling

Furthermore, in July 2018, Sanofi invested about USD 74.1 million in China for establishing an R&D hub to enhance its global reach

Cosmetic interest: It has gained enormous popularity in aesthetics for its potential to alter melanin synthesis and brighten skin tone

A review of animal models of intervertebral disc degeneration: pathophysiology, regeneration, and translation to the clinic

This launch was built around our core beliefs that: People want to be healthy The key to long-term health is to build better habits GLP-1s are powerful meds that make behavior change easier